NL8600383A - Op plaats 4 gesubstitueerde androsteendionderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten, die een dergelijk derivaat bevatten. - Google Patents

Op plaats 4 gesubstitueerde androsteendionderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten, die een dergelijk derivaat bevatten. Download PDF

Info

Publication number
NL8600383A
NL8600383A NL8600383A NL8600383A NL8600383A NL 8600383 A NL8600383 A NL 8600383A NL 8600383 A NL8600383 A NL 8600383A NL 8600383 A NL8600383 A NL 8600383A NL 8600383 A NL8600383 A NL 8600383A
Authority
NL
Netherlands
Prior art keywords
formula
compound
group
dione
hydrogen
Prior art date
Application number
NL8600383A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8600383A publication Critical patent/NL8600383A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8600383A 1985-02-15 1986-02-14 Op plaats 4 gesubstitueerde androsteendionderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten, die een dergelijk derivaat bevatten. NL8600383A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8503940 1985-02-15
GB858503940A GB8503940D0 (en) 1985-02-15 1985-02-15 4-substituted androstendione derivatives

Publications (1)

Publication Number Publication Date
NL8600383A true NL8600383A (nl) 1986-09-01

Family

ID=10574550

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8600383A NL8600383A (nl) 1985-02-15 1986-02-14 Op plaats 4 gesubstitueerde androsteendionderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten, die een dergelijk derivaat bevatten.

Country Status (28)

Country Link
US (1) US4757061A (fr)
JP (1) JPS61189295A (fr)
KR (1) KR930005994B1 (fr)
AT (1) AT396239B (fr)
AU (1) AU577667B2 (fr)
BE (1) BE904226A (fr)
CA (1) CA1319362C (fr)
CH (1) CH669199A5 (fr)
CZ (1) CZ413691A3 (fr)
DE (1) DE3604179A1 (fr)
DK (1) DK167221B1 (fr)
ES (2) ES8706165A1 (fr)
FI (1) FI84272C (fr)
FR (1) FR2577556B1 (fr)
GB (2) GB8503940D0 (fr)
GR (1) GR860430B (fr)
HK (1) HK94090A (fr)
HU (1) HU194909B (fr)
IE (1) IE58864B1 (fr)
IT (1) IT1190335B (fr)
MY (1) MY102038A (fr)
NL (1) NL8600383A (fr)
NZ (1) NZ215163A (fr)
PT (1) PT82030B (fr)
SE (2) SE468515B (fr)
SG (1) SG80890G (fr)
SU (1) SU1574178A3 (fr)
ZA (1) ZA861118B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
WO1991000731A1 (fr) * 1989-07-07 1991-01-24 Endorecherche Inc. Therapie combinee pour la prophylaxie et/ou le traitement de l'hyperplasie prostatique benigne
AU637247B2 (en) * 1990-08-01 1993-05-20 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors
AU642757B2 (en) * 1990-08-01 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
US5519051A (en) * 1991-03-28 1996-05-21 Teikoku Hormone Mfg. Co., Ltd. Oxa- or azasteroid derivatives
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9111260D0 (en) * 1991-05-24 1991-07-17 Erba Carlo Spa Process for the preparation of 4-amino-unsaturated androstanedione derivatives
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
ES2130284T3 (es) * 1992-09-30 1999-07-01 Teikoku Hormone Mfg Co Ltd Compuesto de oxasteroides 7-sustituidos.
NZ261123A (en) * 1993-02-18 1996-08-27 Erba Carlo Spa Fluorinated 4-aminoandrostadienone derivatives
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB2284605A (en) * 1993-12-09 1995-06-14 Erba Carlo Spa 6-or 7-substituted 4-aminoandrostadienone derivatives
EP0758340B1 (fr) * 1994-05-02 1999-01-07 Merrell Pharmaceuticals Inc. Procede concernant la preparation de 4-amino-delta 4-3-ketosteroides en passant par 4-nitro-delta 4-3-ketosteroides
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1203768B (de) * 1962-02-01 1965-10-28 Merck Ag E Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben
DE1668690C3 (de) * 1968-02-29 1978-09-14 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (fr) * 1979-05-02 1983-09-20 Thomas R. Blohm INHIBITEURS DE STEROIDE 5.alpha.-REDUCTASE

Also Published As

Publication number Publication date
FI84272B (fi) 1991-07-31
PT82030A (en) 1986-03-01
FR2577556B1 (fr) 1988-01-08
US4757061A (en) 1988-07-12
IT8619361A0 (it) 1986-02-11
SG80890G (en) 1990-11-23
CZ413691A3 (en) 1994-03-16
KR860006485A (ko) 1986-09-11
AU577667B2 (en) 1988-09-29
ES552052A0 (es) 1987-06-01
BE904226A (fr) 1986-08-14
ATA38886A (de) 1992-11-15
CA1319362C (fr) 1993-06-22
IE58864B1 (en) 1993-11-17
IT1190335B (it) 1988-02-16
GB8503940D0 (en) 1985-03-20
ZA861118B (en) 1986-10-29
GR860430B (en) 1986-06-12
HU194909B (en) 1988-03-28
ES8708235A1 (es) 1987-10-01
HK94090A (en) 1990-11-23
HUT40454A (en) 1986-12-28
SE8600668L (sv) 1986-08-16
JPH0469638B2 (fr) 1992-11-06
SU1574178A3 (ru) 1990-06-23
JPS61189295A (ja) 1986-08-22
GB8603265D0 (en) 1986-03-19
GB2171100B (en) 1988-11-30
ES8706165A1 (es) 1987-06-01
IE860413L (en) 1986-08-15
MY102038A (en) 1992-02-29
ES557215A0 (es) 1987-10-01
GB2171100A (en) 1986-08-20
AU5343386A (en) 1986-08-21
PT82030B (pt) 1988-07-01
AT396239B (de) 1993-07-26
KR930005994B1 (ko) 1993-07-01
CH669199A5 (de) 1989-02-28
FI860672A (fi) 1986-08-16
IT8619361A1 (it) 1987-08-11
FI860672A0 (fi) 1986-02-13
DK71486D0 (da) 1986-02-14
SE8600668D0 (sv) 1986-02-14
FI84272C (fi) 1991-11-11
SE468515B (sv) 1993-02-01
NZ215163A (en) 1988-02-29
DE3604179A1 (de) 1986-08-21
DK167221B1 (da) 1993-09-20
DK71486A (da) 1986-08-16
FR2577556A1 (fr) 1986-08-22

Similar Documents

Publication Publication Date Title
NL8600383A (nl) Op plaats 4 gesubstitueerde androsteendionderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten, die een dergelijk derivaat bevatten.
NL193616C (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
US5091534A (en) Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
JP2791046B2 (ja) アンドロスタ−１，４−ジエン−３，１７−ジオンのメチレン誘導体の製造方法
KR970007948B1 (ko) 17-치환된 안드로스타-1,4-디엔-3-온 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US4865766A (en) Process for the preparation of 4-amino-androstenedione derivatives
US4771043A (en) Steroidic aromatase inhibitors
US5187278A (en) Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-aza-5α-androstan-3-one steroids
HU183495B (en) Process for producing 17-alpha-hydroxy- and 17a-alpha-hydroxy-d-homo-ethiocarboxylic acids
HU199157B (en) Process for producing 17-substituted androsta-1,4-dien-3-one derivatives and pharmaceutical compositions comprising same as active ingredient
HU210544B (en) 4-aza-androstene derivatives substituted with halogenatom in 17-position and process for their production
ITMI942233A1 (it) "derivati 6-o 7-sostituiti del 4-aminoandrostadienone e procedimento per la loro preparazione"

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ERBAMONT INDUSTRIALE S.R.L.

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ERBA S.R.L. FARMITALIA CARLO -

BC A request for examination has been filed
BV The patent application has lapsed